These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27807327)

  • 1. Hyperuricemia is an independent risk factor for 
renal pathological damage and poor prognosis in 
lupus nephritis patients.
    Xie T; Chen M; Tang X; Yin H; Wang X; Li G; Li J; Zuo X; Zhang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1052-1057. PubMed ID: 27807327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
    Hafez EA; Hassan SAE; Teama MAM; Badr FM
    Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
    Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
    Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of estrogen receptor β in renal tubular epithelial cells may cause hyperuricemia in premenopausal patients with systemic lupus erythematosus.
    Liu H; Peng L; Ma J; He L; Long K; Ouyang X; Wu C; Xie M; Dai L; Cai X
    Lupus; 2021 Apr; 30(4):560-567. PubMed ID: 33407049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hyperuricemia and serositis in patients with lupus nephritis.
    Nie P; Hu L; Li B; Lou Y; Luo M; Wang Y; Lu X; Luo P
    Int Urol Nephrol; 2022 Feb; 54(2):357-364. PubMed ID: 33970417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
    Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
    J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid and renal prognosis in patients with IgA nephropathy.
    Ohno I; Hosoya T; Gomi H; Ichida K; Okabe H; Hikita M
    Nephron; 2001 Apr; 87(4):333-9. PubMed ID: 11287777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis.
    Pakchotanon R; Gladman DD; Su J; Urowitz MB
    Lupus; 2018 Mar; 27(3):468-474. PubMed ID: 28857717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.
    Calich AL; Borba EF; Ugolini-Lopes MR; da Rocha LF; Bonfá E; Fuller R
    Clin Rheumatol; 2018 May; 37(5):1223-1228. PubMed ID: 29353328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?
    Ugolini-Lopes MR; Gavinier SS; Leon E; Viana VT; Borba EF; Bonfá E
    Clin Rheumatol; 2019 Oct; 38(10):2777-2783. PubMed ID: 31154554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
    Nezhad ST; Sepaskhah R
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia and its related histopathological features on renal biopsy.
    Fan S; Zhang P; Wang AY; Wang X; Wang L; Li G; Hong D
    BMC Nephrol; 2019 Mar; 20(1):95. PubMed ID: 30885171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
    Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
    J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
    Ayodele OE; Okpechi IG; Swanepoel CR
    Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of lupus nephritis patients with different proportions of crescents.
    Zhang W; Yuan M; Hong L; Zhou Q; Chen W; Yang S; Yang Q; Chen W; Yu X
    Lupus; 2016 Dec; 25(14):1532-1541. PubMed ID: 27060063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients.
    Wantanasiri P; Satirapoj B; Charoenpitakchai M; Aramwit P
    Lupus; 2015 Jul; 24(8):835-45. PubMed ID: 25593049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
    Ding H; Kharboutli M; Saxena R; Wu T
    Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
    Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
    J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
    Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS
    Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.